No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Tislelizumab significantly improves survival outcomes in advanced or metastatic esophageal squamous cell carcinoma

byTeddy Guo

October 5, 2022

in StudyGraphics

Reading Time: 1 min read

Rate of childhood vision screening decreased substantially between 2016 and 2020

RelatedReports

Novel biodegradable sirolimus-eluting stents non-inferior to durable everolimus-eluting stents [BIOSCIENCE trial]

Cardiology

Paclitaxel-coated devices do not reduce rates of major amputations in chronic limb-threatening ischemia

October 31, 2025

Elective neck dissection may be unnecessary for adenoid cystic carcinoma

Oncology

Pembrolizumab improves survival in locally advanced head and neck cancer

August 26, 2025

Niraparib may lengthen progression-free survival for patients with recurrent ovarian cancer

Chronic Disease

Retifanlimab improves progression-free survival in advanced squamous cell anal carcinoma

July 24, 2025

Quick Take: Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma

Chronic Disease

Relacorilant plus nab-paclitaxel improves survival in platinum-resistant ovarian cancer patients

July 23, 2025

PD-1 blocker pembrolizumab may be a promising therapy for advanced Merkel-cell carcinoma

Stereotactic body radiation does not improve outcomes in patients with advanced Merkel cell carcinoma receiving nivolumab and ipilimumab

$#VisualAbstract: Dapagliflozin slows disease progression in patients with heart failure with preserved ejection fraction$

#VisualAbstract: Effectiveness of stand-alone telephone-delivered intervention for reducing problem alcohol use

Provision of medically-tailored meals linked with lower admissions and medical spending

Wellness Check: Nutrition

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports